2nd Abu Dhabi Brain Conference 2022 Program Book

www.uaeneurology.com/brainconference2022 #ADBC2022 Sunday | 18 September 2022 DAY 2 Saturday | 17 September 2022 AGENDA DAY 3 Unveiling Controversies and Trends in Neurosciences ABU DHABI H Y B R I D 2nd MAIN CONFERENCE DAY 3 Neurology or Psychiatry: It’s All One Brain “The Concept of Autoimmune Psychosis” Neurological Complications of Systemic Disease in Movement Disorder Prof. Dr. Souhel Najjar Expanding Role of Complement 5 Inhibitors in Neurological Disorders Q&A Sesssion Closing Remarks & End of Day 2 05:35PM-05:40PM 05:20PM-05:35PM 05:35PM 05:00PM-05:20PM 04:40PM-05:00PM 04:10PM-04:40PM Dr. Fatmah Al Zahmi All Speakers Dr. David Williams SESSION 4: Neurological Complications of Systemic Disease Moderator: Dr. Abdulla Al Kuwaiti & Dr. Tareq Afifi 09:00AM-09:05AM Welcome Message & Introduction Prof. Dr. Naji Riachi Oral Abstracts Session SESSION 5: Moderator: Dr. Mohammed Al Kuwaiti & Prof. Dr. Naji Riachi 09:35AM-09:40AM Q&A Session All Speakers 09:25AM-09:35AM Ms. Engila Khan 09:15AM-09:25AM Variations in Iron Deposition and Iron–regulating Proteins in Mice with Experimental Autoimmune Encephalitis Mr. Ahmed Al-Rawi University of Sharjah UAE University 09:05AM-09:15AM Evaluation of Rotenone Mediated α-synuclein Spreading and Neurotoxicity in Intra-striatal Injection of α-synuclein PFF Model of Parkinson’s Disease Dr. Nisreen Bader Fujeirah Hospital Oral Abstract Winner Oral Abstract Winner Oral Abstract Winner REGISTRATIONOPEN 08:00AM Saqr Ballroom A&B Saqr Ballroom A&B 10:55AM- 11:15AM 11:15AM- 11:30AM Q&A Session COFFEE BREAK 10:40AM- 10:55AM TBA All Speakers Optimizing Clinical Outcomes of gMG: What’s New in 2022? Updates in Amyotrophic Lateral Sclerosis Therapeutics 10:00AM- 10:20AM Dr. Zulfiqar Hussain Neuropathic Pain Management 10:20AM- 10:40AM Dr. Abdullah Al-Salti Moderator: Dr. Najwa Al-Bustani & Dr. Zakaria Ammache Nerve and Muscle Disease SESSION 6: Saqr Ballroom A&B 09:40AM- 10:00AM Updates in Myasthenia Gravis Management Options Dr. Abubaker Al Madani Prof. Nils Erik Gilhus Ocrelizumab: A Breakthrough Therapeutic Approach in Pediatric-onset Multiple Sclerosis TABLET WINNER ANNOUNCEMENT